Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E27P | ISIN: CA30053H1055 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
EVOME MEDICAL TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
EVOME MEDICAL TECHNOLOGIES INC 5-Tage-Chart

Aktuelle News zur EVOME MEDICAL TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
EVOME MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln
08.05.Evome Medical Technologies Inc: Evome Medical suspended by BCSC1
10.04.Evome Medical Technologies Inc: Evome Medical chairman Dalsin resigns1
09.04.Evome Medical Technologies Inc.: Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies91NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. ("Evome", the "Company") (TSXV: EVMT) announced the resignation of Michael Dalsin as Chairman of the Board of Directors....
► Artikel lesen
28.03.Evome Medical Technologies Inc: Evome lender to quit lending to Evome units, mgmt quits2
28.03.Evome Medical Technologies Inc.: Evome Medical Technologies Provides Market Update153NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) is providing an update to shareholders today. As important background: Evome generates...
► Artikel lesen
17.03.Evome Medical Technologies Inc: Evome Medical appoints Dalsin as chairman-
17.03.Evome Medical Technologies names Michael Dalsin as chair1
17.03.Evome Medical Technologies Inc.: Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six2
12.02.Evome Medical Technologies Inc: Evome clarifies debt reduction, monthly payments2
12.02.Evome Medical Technologies Inc.: CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring2
10.02.Evome Medical Technologies Inc: Evome amends forbearance agreement, reduces debt1
10.02.Evome Medical Technologies Inc.: Evome Medical Technologies Announces Significant Debt Reduction and Restructuring139SHIRLEY, N.Y., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company") (TSXV: EVMT) has announced a significant reduction in its overall debt, strengthening its financial...
► Artikel lesen
20.01.Evome Medical Technologies Inc.: Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer3
25.11.24Evome Medical Technologies Inc.: Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt173SHIRLEY, N.Y., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Shirley, New York, November 25, 2024 - Evome Medical Technologies Inc. (the "Company") (TSXV: EVMT) today reported financial results for the third...
► Artikel lesen
08.11.24Evome Medical Technologies Inc.: Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders123SHIRLEY, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) today announced ?the results from its annual general and special meeting of...
► Artikel lesen
15.08.24Evome Medical Technologies Inc.: Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan206Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical...
► Artikel lesen
12.08.24Evome Medical Technologies Inc.: Evome Medical Technologies Reports Second Quarter 2024 Financial Results539Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug....
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1